Stimulating severe COVID-19: the potential role of GM-CSF antagonism
Lancet Respir Med
.
2022 Mar;10(3):223-224.
doi: 10.1016/S2213-2600(21)00539-7.
Epub 2021 Dec 1.
Authors
Helen L Leavis
1
,
Frank L van de Veerdonk
2
,
Srinivas Murthy
3
Affiliations
1
Department of Rheumatology and Clinical Immunology, Utrecht University, University Medical Center Utrecht, Netherlands.
2
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
3
Faculty of Medicine, University of British Columbia, Vancouver, BC V6H 3V4, Canada. Electronic address:
[email protected]
.
PMID:
34863335
PMCID:
PMC8635456
DOI:
10.1016/S2213-2600(21)00539-7
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Granulocyte-Macrophage Colony-Stimulating Factor* / therapeutic use
Humans
SARS-CoV-2
Substances
Granulocyte-Macrophage Colony-Stimulating Factor